BioPharma Dive » Clinical Trials
5 FOLLOWERS
This section of the BioPharma Dive library features a distinct collection of articles sharing ideas and perceptive, medical acumen on the topic of Clinical Trials. A leading Clinical publication and website, BioPharma Dive provides in-depth journalism and insight into the most impactful news and trends shaping biotech and pharma.
BioPharma Dive » Clinical Trials
2d ago
While some new drug studies are getting underway, activity is still far below bustling pre-war levels ..read more
BioPharma Dive » Clinical Trials
2d ago
Shares of the biotech rose about 5% after a medicine licensed from Takeda hit the main and key secondary goals of a mid-stage study focused on major depressive disorder ..read more
BioPharma Dive » Clinical Trials
2d ago
The drug benefited people whose tumors have “ultralow” levels of HER2 protein, a result that could extend its reach in HER2-positive breast cancer ..read more
BioPharma Dive » Clinical Trials
2d ago
The company will soon start a Phase 1/2 study of its treatment for chronic granulomatous disease, a milestone for the search-and-replace gene editing technology ..read more
BioPharma Dive » Clinical Trials
1w ago
The company said the pause is necessary to meet regulatory limits on nitrosamine, but added it will not affect commercial supply nor regulatory review of the drug in early breast cancer ..read more
BioPharma Dive » Clinical Trials
1w ago
Treatment appeared to result in functional and cognitive gains in people with the neurological disorder. Three participants experienced lower extremity weakness, however ..read more
BioPharma Dive » Clinical Trials
1w ago
The decision clears a concern hanging over GLP-1 medicines like Ozempic since reports of suicidal ideation and self-harm among people taking the drugs surfaced in July ..read more
BioPharma Dive » Clinical Trials
1w ago
The results could give Roche’s Columvi an edge over a rival medicine from AbbVie and Genmab, while Regeneron awaits an approval of its own therapy ..read more
BioPharma Dive » Clinical Trials
1w ago
Shares of the biotech dipped by double digits following disclosure the FDA had paused an early-stage study of Neumora’s muscarinic-targeting drug ..read more
BioPharma Dive » Clinical Trials
1w ago
Shares of the biotech rose 25% after a large trial found adding its drug Caplyta onto antidepressant therapy significantly helped people with major depression ..read more